Cargando…
The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354138/ https://www.ncbi.nlm.nih.gov/pubmed/32676343 http://dx.doi.org/10.21037/tlcr.2020.01.14 |
| _version_ | 1783558022405029888 |
|---|---|
| author | Ichiki, Yoshinobu Fukuyama, Takashi Nakanishi, Kozo |
| author_facet | Ichiki, Yoshinobu Fukuyama, Takashi Nakanishi, Kozo |
| author_sort | Ichiki, Yoshinobu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7354138 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73541382020-07-15 The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung Ichiki, Yoshinobu Fukuyama, Takashi Nakanishi, Kozo Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2020-06 /pmc/articles/PMC7354138/ /pubmed/32676343 http://dx.doi.org/10.21037/tlcr.2020.01.14 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Ichiki, Yoshinobu Fukuyama, Takashi Nakanishi, Kozo The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung |
| title | The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung |
| title_full | The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung |
| title_fullStr | The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung |
| title_full_unstemmed | The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung |
| title_short | The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung |
| title_sort | prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354138/ https://www.ncbi.nlm.nih.gov/pubmed/32676343 http://dx.doi.org/10.21037/tlcr.2020.01.14 |
| work_keys_str_mv | AT ichikiyoshinobu theprospectofcombinationtherapywithimmunecheckpointinhibitorsandchemotherapyforsquamouscellcarcinomaofthelung AT fukuyamatakashi theprospectofcombinationtherapywithimmunecheckpointinhibitorsandchemotherapyforsquamouscellcarcinomaofthelung AT nakanishikozo theprospectofcombinationtherapywithimmunecheckpointinhibitorsandchemotherapyforsquamouscellcarcinomaofthelung AT ichikiyoshinobu prospectofcombinationtherapywithimmunecheckpointinhibitorsandchemotherapyforsquamouscellcarcinomaofthelung AT fukuyamatakashi prospectofcombinationtherapywithimmunecheckpointinhibitorsandchemotherapyforsquamouscellcarcinomaofthelung AT nakanishikozo prospectofcombinationtherapywithimmunecheckpointinhibitorsandchemotherapyforsquamouscellcarcinomaofthelung |